S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:LPCN

Lipocine (LPCN) Stock Price, News & Analysis

$5.20
+0.07 (+1.36%)
(As of 03/28/2024 ET)
Today's Range
$4.85
$5.30
50-Day Range
$3.58
$5.21
52-Week Range
$2.31
$5.95
Volume
48,922 shs
Average Volume
30,535 shs
Market Capitalization
$27.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Lipocine MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
2.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.33mentions of Lipocine in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($1.75) to ($2.06) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.05 out of 5 stars

Medical Sector

934th out of 938 stocks

Pharmaceutical Preparations Industry

416th out of 417 stocks

LPCN stock logo

About Lipocine Stock (NASDAQ:LPCN)

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1154 for postpartum depression; LPCN 2101 for women with epilepsy; and LPCN 1148, a novel prodrug of testosterone, testosterone laurate for the management of decompensated cirrhosis. It also develops LPCN 1144, an oral prodrug of androgen receptor modulator for the treatment of non-cirrhotic non-alcoholic steatohepatitis, which has completed Phase II testing; LPCN 1111, an oral TRT product of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical testing; and LPCN 1107, an oral hydroxy progesterone caproate product for the prevention of recurrent preterm birth. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.

LPCN Stock Price History

LPCN Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023
Lipocine GAAP EPS of -$3.14
Lipocine to Present at 36th Annual Roth Conference
Lipocine Signs TLANDO Franchise License Deal With Verity Pharma
Lipocine to Present at Biotech Showcase 2024
Lipocine files for $150M mixed shelf
See More Headlines
Receive LPCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
3/29/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LPCN
Employees
17
Year Founded
1997

Profitability

Net Income
$-16,350,000.00
Pretax Margin
-21,921.82%

Debt

Sales & Book Value

Annual Sales
$500,000.00
Book Value
$3.83 per share

Miscellaneous

Free Float
5,050,000
Market Cap
$27.66 million
Optionable
No Data
Beta
1.02

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Mahesh V. Patel Ph.D. (Age 67)
    Co-Founder, Interim Principal Financial Officer, Director, President & CEO
    Comp: $598.91k
  • Ms. Krista Fogarty (Age 56)
    Principal Accounting Officer & Corporate Controller
    Comp: $268.12k
  • Dr. Nachiappan Chidambaram Ph.D. (Age 54)
    Senior Vice President of Research & Development
    Comp: $311.17k
  • Mr. Logan Morse (Age 54)
    Vice President of Sales, Marketing & Operations
    Comp: $413.58k
  • Mr. Morgan R. Brown CPA (Age 56)
    M.B.A., Corporate Secretary
    Comp: $472.45k

LPCN Stock Analysis - Frequently Asked Questions

How have LPCN shares performed in 2024?

Lipocine's stock was trading at $2.79 at the start of the year. Since then, LPCN shares have increased by 86.4% and is now trading at $5.20.
View the best growth stocks for 2024 here
.

When is Lipocine's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our LPCN earnings forecast
.

How were Lipocine's earnings last quarter?

Lipocine Inc. (NASDAQ:LPCN) announced its quarterly earnings results on Thursday, March, 7th. The specialty pharmaceutical company reported ($0.42) EPS for the quarter, topping the consensus estimate of ($0.53) by $0.11. The specialty pharmaceutical company had revenue of $0.22 million for the quarter.

When did Lipocine's stock split?

Lipocine shares reverse split on Friday, May 12th 2023. The 1-17 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of Lipocine own?
Who are Lipocine's major shareholders?

Lipocine's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wealth Effects LLC (0.28%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Krista Fogarty, Mahesh V Patel, Richard Dana Ono and Spyros Papapetropoulos.
View institutional ownership trends
.

How do I buy shares of Lipocine?

Shares of LPCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LPCN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners